Upcoming Global IPOs
The IPOX® Newsletters
IPOX® in the News
IPOX® CEO Josef Schuster commented on YPF Electric Energy’s U.S. IPO filing, highlighting the company’s significant scale and position among Argentina’s leading utilities. He said the strong debut of Korea’s SK Hynix demonstrated that U.S. markets remain receptive to large foreign listings, helping motivate YPF Electric Energy to pursue a NYSE debut. The company reported a 45.8% increase in quarterly revenue and plans to trade under the ticker “YLUZ,” with investor interest supported by improving sentiment toward Argentina’s energy sector.
Reuters reported that Brookfield-backed data center provider Csquare was valued at $3.2 billion after a subdued NYSE debut, with shares closing below the $21 IPO price. IPOX® Research Associate Lukas Muehlbauer said investors viewed the company’s AI infrastructure exposure alongside substantial leverage and continued losses, prompting disciplined pricing. He added that the successful deal still showed the IPO market remains open to AI infrastructure companies, although investor demand appears selective rather than overheated in the current, cautious new-issue market environment.
IPOX® CEO Josef Schuster commented on Standard Nuclear’s decision to cut its proposed U.S. IPO by more than half, lowering its targeted valuation to $2.4 billion amid cautious investor sentiment. He said weak performance among recent IPOs, including SpaceX, is weighing on demand for high-risk, loss-making offerings. Schuster also noted that sector-specific weakness, reflected in declines for NuScale Power and Oklo, is creating a more challenging pricing environment ahead of Standard Nuclear’s planned NYSE debut during its New York launch.
Seeking Alpha featured an analysis of the First Trust US Equity Opportunities ETF (FPX), highlighting the fund’s tracking of the IPOX® 100 U.S. Index. The article discusses FPX as a diversified ETF for exposure to U.S. companies that have recently gone public, with a focus on index methodology, sector positioning, recent performance, and risk profile. It also examines how IPO market trends, AI enthusiasm, and corporate spinoffs may shape the fund’s opportunity set.
IPOX® CEO Josef Schuster told Reuters that Londian Wason New Energy Tech’s U.S. IPO filing could mark an important step for larger Chinese issuers seeking access to U.S. equity markets. Schuster noted that, if successful, the offering may help reopen the U.S. IPO market for bigger China-based deals. He also highlighted Londian’s position as a leading manufacturer of a key battery component, suggesting the company could attract investor interest despite pending pricing details.
The IPOX® Update
Global IPO activity is accelerating, led by large technology and infrastructure deals. In the U.S., Switch, Anthropic, Holtec, JERA and YPF Electric Energy are pursuing or considering listings. Europe remains mixed, with Utmost and Howden advancing plans while AS Watson may delay. Asia-Pacific is especially active: CXMT has raised $8.6 billion, while Zhongji Innolight, Eoptolink, Shein, AirTrunk, DeepSeek and Kopi Kenangan prepare offerings, though Syngenta’s Hong Kong IPO could slip to 2027. Market conditions and regulatory approvals remain key uncertainties.
Global IPO activity is gaining momentum across the United States, Europe and Asia-Pacific. DuPont Registry, Ennismore, Syntiant and Scribe Therapeutics are advancing U.S. listings, while Digi Spain has priced a €330 million offering at €5.60 per share. In Asia, AI chipmaker Rebellions is targeting a South Korean IPO in 2027, with a possible U.S. ADR to follow. The deals highlight renewed investor appetite across luxury, hospitality, telecom, biotechnology and artificial intelligence sectors amid improving market conditions and stronger global sentiment.
Recent IPO activity shows renewed breadth across U.S. and European markets, with large listings and filings spanning restaurants, consumer retail, fintech, digital infrastructure, defence, telecom and healthcare real estate. In the U.S., Jersey Mike’s, Nutrabolt, iHerb and several Nasdaq debutants highlight stronger investor appetite, while Europe’s pipeline includes KNDS, Dusk, Infracore, Digi Spain and Smag. Although market volatility remains a constraint, IPO momentum appears to be broadening beyond AI-led growth stories and defensive consumer names across public equity markets today.